Mediolanum International Funds Ltd Lowers Holdings in Agilent Technologies, Inc. $A

Mediolanum International Funds Ltd trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 30.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 15,900 shares of the medical research company’s stock after selling 7,074 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Agilent Technologies were worth $1,781,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Arjuna Capital boosted its position in Agilent Technologies by 1.2% during the 1st quarter. Arjuna Capital now owns 10,015 shares of the medical research company’s stock valued at $1,142,000 after acquiring an additional 121 shares in the last quarter. Modera Wealth Management LLC boosted its stake in Agilent Technologies by 2.3% in the 1st quarter. Modera Wealth Management LLC now owns 33,650 shares of the medical research company’s stock worth $3,835,000 after purchasing an additional 753 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Agilent Technologies by 14.5% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 223,463 shares of the medical research company’s stock valued at $25,595,000 after acquiring an additional 28,286 shares during the period. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in Agilent Technologies in the 1st quarter worth approximately $5,345,000. Finally, Noesis Capital Mangement Corp raised its holdings in shares of Agilent Technologies by 4.7% during the first quarter. Noesis Capital Mangement Corp now owns 132,538 shares of the medical research company’s stock worth $15,107,000 after purchasing an additional 6,006 shares during the last quarter. 87.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on A shares. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. TD Cowen raised their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Piper Sandler initiated coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Wells Fargo & Company lowered their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Trading Up 2.1%

Shares of NYSE A opened at $133.04 on Wednesday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $37.58 billion, a PE ratio of 26.72, a PEG ratio of 2.31 and a beta of 1.25. The stock has a fifty day simple moving average of $128.27 and a 200-day simple moving average of $125.47. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 6.01 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.